Skip to main content
search

Preclinical

Sign up

Latest resources

Featured resource

Upcoming preclinical webinars

Latest preclinical blogs

Meet our experts at the following events

Conference

2026 ACCP Annual Meeting

September 27 - 29, 2026 – Bethesda N Marriott Hotel & Conf Ctr N Bethesda, MD
Conference

BioTechX Europe 2026

October 6 - 8, 2026
Conference

ISSX 27th North American Meeting

October 11 - 14, 2026 – San Francisco, CA

All preclinical resources

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

Biologics, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, Poster

EANM 2026

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Therapeutic Specialties, Conference

From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, Webinar

Model smarter, not harder: how Phoenix Cloud puts the science back at the center of modeling

Certara Products - Phoenix, Model Informed Drug Development, Modeling and Simulation - PK/PD, Blog

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Publication

A Quantitative Systems Pharmacology Comparison Of Tau-targeted Therapeutic Strategies In Alzheimer’s Disease

Central Nervous System (CNS), Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Poster

AI, HTA, and the Future of Access: Inside the 12th Annual Kraków HTA Symposium

Market Access, Modeling and Simulation, Blog

Recommendations for Adopting New Approach Methodologies to Reduce Animal Testing in Drug Development

New Approach Methodologies (NAMs), eBook

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

Certara Products - Simcyp, Drug Development, ICH M15, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), On-Demand Webinar

5 Key Principles of Modern PK/PD in 2026

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Guide

Development of a human PBMC TXG-MAPr as a mechanistic framework to interpret toxicodynamic variability across the human population

Certara Services, Poster

Characterization of human toxicodynamic variability using peripheral blood mononuclear cells from a large cohort of healthy volunteers

Certara Services, Poster
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.